| 產(chǎn)品名稱 | Burkholderia dolosa Vermis et al. |
|---|---|
| 商品貨號 | B162365 |
| Deposited As | Burkholderia cepacia (Palleroni and Holmes) Yabuuchi et al. |
| Strain Designations | LMG 18941 |
| Isolation | Clinical specimen - human United States |
| Biosafety Level | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties | Genomovar VI
Ref  Coenye T, et al. . Int. J. Syst. Evol. Microbiol. : . |
| Product Format | freeze-dried |
| Preceptrol® | no |
| Type Strain | no |
| Medium | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions | Temperature: 30.0°C Atmosphere: Aerobic |
| Name of Depositor | BCCM/LMG Laboratory of Microbiology |
| Special Collection | NCRR Contract |
| References | Coenye T, et al. . Int. J. Syst. Evol. Microbiol. : . cystic fibrosis patient Coenye T, et al. . Int. J. Syst. Evol. Microbiol. : . Coenye T, et al. . Int. J. Syst. Evol. Microbiol. : . |
| Cross References | Nucleotide (GenBank) : AF175314 Burkholderia cepacia 16S ribosomal RNA gene, partial sequence. |
| 梅經(jīng)理 | 17280875617 | 1438578920 |
| 胡經(jīng)理 | 13345964880 | 2438244627 |
| 周經(jīng)理 | 17757487661 | 1296385441 |
| 于經(jīng)理 | 18067160830 | 2088210172 |
| 沈經(jīng)理 | 19548299266 | 2662369050 |
| 李經(jīng)理 | 13626845108 | 972239479 |
